DERM
Journey Medical Achieves Milestone Year with $14.7 Million in Net Sales from Newly Launched EMROSI Treatment
On March 25, 2026, Journey Medical's leadership team, including Co-founder and President Claude Maraoui, Chief Financial Officer Joseph Benesch, and Chief Operating Officer and General Counsel Ramsey Alloush, presented the company's Full Year 2025 Financial Results and Corporate Update during a conference call. During the call,